dotarizine has been researched along with thapsigargin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abad-Santos, F; Alonso, MT; Alvarez, J; García, AG; Montero, M; Novalbos, J; Zapater, P | 1 |
| Abad-Santos, F; Arias, E; Cano-Abad, MF; Gallego-Sandín, S; García, AG; Novalbos, J; Rosado, A | 1 |
2 other study(ies) available for dotarizine and thapsigargin
| Article | Year |
|---|---|
Novel antimigraineur dotarizine releases Ca2+ from caffeine-sensitive Ca2+ stores of chromaffin cells.
Topics: Adrenal Medulla; Animals; Benzhydryl Compounds; Caffeine; Calcium; Cattle; Cells, Cultured; Chromaffin Cells; Flunarizine; Indoles; Migraine Disorders; Piperazines; Potassium; Thapsigargin; Vasodilator Agents | 1999 |
Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells.
Topics: Apoptosis; Benzhydryl Compounds; Calcium; Calcium Channel Blockers; Cell Line, Tumor; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Flunarizine; Humans; Membrane Potentials; Mitochondria; Neuroblastoma; Piperazines; Serum Albumin, Bovine; Thapsigargin; Time Factors | 2005 |